98%
921
2 minutes
20
Recent innovation in trial design to improve study efficiency has led to the development of basket trials in which a single therapeutic treatment is tested on several patient populations, each of which forms a basket. In a common setting, patients across all baskets share a genetic marker and as such, an assumption can be made that all patients may have a homogeneous response to treatments. Bayesian information borrowing procedures utilize this assumption to draw on information regarding the response in one basket when estimating the response rate in others. This can improve power and precision of estimates particularly in the presence of small sample sizes, however, can come at a cost of biased estimates and an inflation of error rates, bringing into question validity of trial conclusions. We review and compare the performance of several Bayesian borrowing methods, namely: the Bayesian hierarchical model (BHM), calibrated Bayesian hierarchical model (CBHM), exchangeability-nonexchangeability (EXNEX) model and a Bayesian model averaging procedure. A generalization of the CBHM is made to account for unequal sample sizes across baskets. We also propose a modification of the EXNEX model that allows for better control of a type I error. The proposed method uses a data-driven approach to account for the homogeneity of the response data, measured through Hellinger distances. Through an extensive simulation study motivated by a real basket trial, for both equal and unequal sample sizes across baskets, we show that in the presence of a basket with a heterogeneous response, unlike the other methods discussed, this model can control type I error rates to a nominal level whilst yielding improved power.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10962580 | PMC |
http://dx.doi.org/10.1002/sim.9867 | DOI Listing |
Stat Methods Med Res
September 2025
Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
The integration of backfill cohorts into Phase I clinical trials has garnered increasing interest within the clinical community, particularly following the "Project Optimus" initiative by the U.S. Food and Drug Administration, as detailed in their final guidance of August 2024.
View Article and Find Full Text PDFBiometrics
July 2025
Department of Biostatistics, Institute of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
When incorporating historical control data into the analysis of current randomized controlled trial data, it is critical to account for differences between the datasets. When the cause of difference is an unmeasured factor and adjustment for only observed covariates is insufficient, it is desirable to use a dynamic borrowing method that reduces the impact of heterogeneous historical controls. We propose a nonparametric Bayesian approach that addresses between-trial heterogeneity and allows borrowing historical controls homogeneous with the current control.
View Article and Find Full Text PDFAm J Obstet Gynecol
August 2025
Office of the Center Director, National Center for Health Statistics, CDC.
Background: The United States maternal mortality rate increased after 2018, with a marked increase in 2021 followed by a decline in 2022 and 2023. Trends at the state level have not yet been examined, likely due to the small numbers of maternal deaths occurring annually in most states. Small area estimation models can provide more reliable estimates of maternal mortality at the state level, by borrowing strength over time and across geographic areas.
View Article and Find Full Text PDFJ Biopharm Stat
August 2025
Department of Biostatistics, NHC Key Laboratory for Health Technology Assessment, Key Laboratory of Public Health Safety of Ministry of Education, School of Public Health, Fudan University, Shanghai, China.
Propensity score-integrated Bayesian dynamic borrowing methods offer an effective approach for covariate adjustment when using external data to augment randomized controlled trials (RCTs). However, identifying the correct propensity score model can be challenging due to unknown treatment selection processes, potentially leading to model misspecification and biased estimates. To improve robustness to model misspecification, we propose an innovative Bayesian inference procedure that incorporates multiply robust weights into the construction of informative power priors.
View Article and Find Full Text PDFStat Med
August 2025
Department of Biostatistics, Erasmus MC, Rotterdam, the Netherlands.
The incorporation of real-world data to supplement the analysis of trials and improve decision-making has spurred the development of statistical techniques to account for introduced confounding. Recently, "hybrid" methods have been developed through which measured confounding is first attenuated via propensity scores and unmeasured confounding is addressed through (Bayesian) dynamic borrowing. Most efforts to date have focused on augmenting control arms with historical controls.
View Article and Find Full Text PDF